Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Response Interaction of Metoprolol and Sufentanil for Attenuating Hemodynamic Responses in Tracheal Intubation
NCT07597564Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Jun 2026
- Primary completion
- May 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of metoprolol, sufentanil, sponsored by Fujian Provincial Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
metoprololsufentanil
Beyond the preview
Go deeper on NCT07597564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07597564.